Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Sheng B, Gao S, Chen X, Liu Y, Lai N, Dong J, Sun J, Zhou Y, et al
We screen for this at consultation
At baseline, most patients (97%) were treated with one or more glucose-lowering medications, including metformin (76%), insulin (51%), SGLT-2i (27%), sulfonylurea (29%), and DPP-4i (23%) with CV disease and risk factors managed with lipid-lowering medications (89%), platelet-aggregation inhibitors including aspirin (77%), angiotensin converting enzyme inhibitors or angiotensin II receptor blockers (79%), and beta blockers (64%)
The Green Analytical Procedure Index (GAPI) and Analytical GREENNESS metric approach (AGREE) were the two metric tools used in the current study to assess the exceptional greenness of the suggested procedure 35,36
Gassmann M, Mairburl H, Livshits L, Hackbusch M, Malczyk M, Kraut S, et al
PMCID: PMC2645018
US$ 27.85
US$ 21.28
US$ 27.96
